Anti-Bromodeoxyuridine mAb (Monoclonal Antibody)
MI-11-3
Antibody
100 μg
BrdU (5-Bromo-2-Deoxyuridine) is a derivative of uridine that can substitute for thymidine during DNA synthesis. The detection of BrdU incorporation into DNA is a common method to quantify newly synthesized DNA and to identify cells in the S-phase of the cell cycle. BrdU incorporation is frequently used in proliferation assays to study DNA repair, sister chromatid exchange, and the cytokinetics of normal and neoplastic cells.
Monoclonal Antibody targets BrdU for FCM, ICC, IHC.
| Target | BrdU |
|---|---|
| Product Type | Antibody |
| Application | FCM, ICC, IHC |
| Clonality | Monoclonal |
| Conjugate | Unlabeled |
| Isotype | IgG1 |
| Immunogen | 5-Iodouridine-Ovalbumin |
| Host Species | Mouse |
| Species Reactivity | Human |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Research Area | Cancer, Immunology |
| Storage Temperature | -20°C |
| Protocols | FCM, ICC, IHC |
| Clone Number | 2B1 |
| Concentration | 1 mg/mL |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
MI-11-3
Antibody
100 μg